×
About 193 results

ALLMedicine™ Transjugular Liver Biopsy Center

Research & Reviews  64 results

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
https://clinicaltrials.gov/ct2/show/NCT03520660

Jun 24th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...

Haemophagocytic lymphohistiocytosis associated with bartonella peliosis hepatis followi...
https://doi.org/10.1016/S1473-3099(22)00276-6
The Lancet. Infectious Diseases; Steed D, Collins J et. al.

May 3rd, 2022 - Bacillary peliosis hepatis is a well recognised manifestation of disseminated Bartonella henselae infection that can occur in immunocompromised individuals. Haemophagocytic lymphohistiocytosis is an immune-mediated condition with features that can...

Transjugular Liver Biopsy
https://emedicine.medscape.com/article/1423263-overview

Jan 27th, 2022 - Background Transjugular liver biopsy was first performed in 1970 and is now an accepted method of liver biopsy when the percutaneous technique is contraindicated. [1, 2] Some clinicians have considered this technique to be inferior to the percutan...

Transjugular Liver Biopsy
https://emedicine.medscape.com/article/1423263-print

Jan 27th, 2022 - Background Transjugular liver biopsy was first performed in 1970 and is now an accepted method of liver biopsy when the percutaneous technique is contraindicated.[1, 2] Some clinicians have considered this technique to be inferior to the percutane...

Transjugular Liver Biopsy
http://emedicine.medscape.com/article/1423263-overview

Jan 27th, 2022 - Background Transjugular liver biopsy was first performed in 1970 and is now an accepted method of liver biopsy when the percutaneous technique is contraindicated. [1, 2] Some clinicians have considered this technique to be inferior to the percutan...

see more →

Clinicaltrials.gov  11 results

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
https://clinicaltrials.gov/ct2/show/NCT03520660

Jun 24th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...

Comparison of 19g FNA and 19g FNB Needles for EUS-LB
https://clinicaltrials.gov/ct2/show/NCT03408171

Apr 14th, 2020 - Chronic liver disorders (CLD) are a major cause of morbidity and mortality for individuals in the US. Though serologic analysis will often lead to a conclusive diagnosis, liver biopsy remains an important method for helping to determine the etiolo...

Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
https://clinicaltrials.gov/ct2/show/NCT01644656

Sep 6th, 2018 - DESIGN The study is designed as a prospective, cross-sectional, diagnostic study in which the investigators will evaluate the use of ARFI to diagnose clinically significant portal hypertension (CSPH defined as hepatic veous pressure gradient (HVPG...

To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase
https://clinicaltrials.gov/ct2/show/NCT02788240

Feb 6th, 2018 - All consecutive ACLF (Acute on Chronic Liver failure) patients presenting to the institute of liver and biliary sciences, irrespective of the etiology , who have survived the acute phase (i.e. 90 days of onset of the acute on chronic liver failure...

Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy
https://clinicaltrials.gov/ct2/show/NCT02311348

Jul 2nd, 2017 - Millions of Americans are diagnosed with some form of Hepatitis or other liver disease requiring treatment. Liver biopsies are frequently performed mainly to stage disease, aid in diagnosis and to guide treatment. As part of the assessment of Hepa...

see more →

News  1 results

Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment
https://www.onclive.com/view/advanced-systemic-mastocytosis-expert-insight-into-epidemiology-diagnosis-and-treatment

Sep 15th, 2021 - SYSTEMIC MASTOCYTOSIS (SM) is a rare disease that often first presents on the skin. It is characterized by the overaccumulation of mast cells (MCs), which can then penetrate such internal organs as bone marrow (BM).¹ Challenges in identification a...

see more →

Patient Education  1 results see all →